HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Genetic Determinants of Axial Length: From Microphthalmia to High Myopia in Childhood.

Abstract
The axial length of the eye is critical for normal visual function by enabling light to precisely focus on the retina. The mean axial length of the adult human eye is 23.5 mm, but the molecular mechanisms regulating ocular axial length remain poorly understood. Underdevelopment can lead to microphthalmia (defined as a small eye with an axial length of less than 19 mm at 1 year of age or less than 21 mm in adulthood) within the first trimester of pregnancy. However, continued overgrowth can lead to axial high myopia (an enlarged eye with an axial length of 26.5 mm or more) at any age. Both conditions show high genetic and phenotypic heterogeneity associated with significant visual morbidity worldwide. More than 90 genes can contribute to microphthalmia, and several hundred genes are associated with myopia, yet diagnostic yields are low. Crucially, the genetic pathways underpinning the specification of eye size are only now being discovered, with evidence suggesting that shared molecular pathways regulate under- or overgrowth of the eye. Improving our mechanistic understanding of axial length determination will help better inform us of genotype-phenotype correlations in both microphthalmia and myopia, dissect gene-environment interactions in myopia, and develop postnatal therapies that may influence overall eye growth.
AuthorsDaniel Jackson, Mariya Moosajee
JournalAnnual review of genomics and human genetics (Annu Rev Genomics Hum Genet) Vol. 24 Pg. 177-202 (08 25 2023) ISSN: 1545-293X [Electronic] United States
PMID37624667 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Female
  • Pregnancy
  • Humans
  • Microphthalmos (genetics)
  • Myopia (genetics)
  • Gene-Environment Interaction
  • Multiple Birth Offspring
  • Pregnancy Trimester, First

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: